Dextromethorphan hydrobromide

Discontinued Product

3071 has been discontinued.

View all NMDA Receptors products.
Description: NMDA antagonist
Chemical Name: (9α,13α,14α)-3-Methoxy-17-methylmorphinan hydrobromide
Purity: ≥99% (HPLC)
Datasheet
Citations (1)
Reviews
Literature (5)

Biological Activity for Dextromethorphan hydrobromide

Non-competitive, low affinity NMDA receptor antagonist. Antitussive, anticonvulsive and neuroprotective agent.

Technical Data for Dextromethorphan hydrobromide

M. Wt 352.31
Formula C18H25NO.HBr
Storage Store at RT
Purity ≥99% (HPLC)
CAS Number 125-69-9
PubChem ID 5464025
InChI Key MISZALMBODQYFT-URVXVIKDSA-N
Smiles [H][C@@]12[C@@H]4CC(C=CC(OC)=C3)=C3[C@@](CCN4C)1CCCC2.Br

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Dextromethorphan hydrobromide

References for Dextromethorphan hydrobromide

References are publications that support the biological activity of the product.

Choi et al (1987) Dextrorophan and levorp. selectively block N-MthD.-aspartate receptor-mediated neurotoxicity on corticol neurons. J.Pharmacol.Exp.Ther. 242 713 PMID: 3039122

Keller et al (2008) Dextromethorphan is protective against sensitized N-MthD.-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain. Eur.J.Neurosci. 27 874 PMID: 18279363

View Related Products by Target

View Related Products by Product Action

View all NMDA Receptor Antagonists

Keywords: Dextromethorphan hydrobromide, Dextromethorphan hydrobromide supplier, NMDA, receptor, antagonists, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic, 6700-34-1, 3071, Tocris Bioscience

1 Citation for Dextromethorphan hydrobromide

Citations are publications that use Tocris products. Selected citations for Dextromethorphan hydrobromide include:

Ghoshooni et al (2011) Milled Stress Reduces Morphine-Induced Locomotion in F2 NMRI Mice. Pharmacol Res Perspect 10 347 PMID: 24250364


Reviews for Dextromethorphan hydrobromide

There are currently no reviews for this product. Be the first to review Dextromethorphan hydrobromide and earn rewards!

Have you used Dextromethorphan hydrobromide?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells
Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Huntington's Disease Poster

Huntington's Disease Poster

Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.